Realizing drug repositioning by adapting a recommendation system to handle the process
暂无分享,去创建一个
Tansel Özyer | Reda Alhajj | Faruk Polat | Makbule Guclin Ozsoy | R. Alhajj | Faruk Polat | Tansel Özyer | Makbule Gülçin Özsoy
[1] Pankaj Agarwal,et al. Systematic Drug Repositioning Based on Clinical Side-Effects , 2011, PloS one.
[2] Priya Nambisan,et al. Using Social Media Data to Identify Potential Candidates for Drug Repurposing: A Feasibility Study , 2016, JMIR research protocols.
[3] Mark Goadrich,et al. The relationship between Precision-Recall and ROC curves , 2006, ICML.
[4] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[5] Guanghui Hu,et al. Human Disease-Drug Network Based on Genomic Expression Profiles , 2009, PloS one.
[6] Yanli Wang,et al. PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..
[7] Jacob K. Asiedu,et al. The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.
[8] P. Bork,et al. A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.
[9] G. Schneider,et al. Predicting Compound Selectivity by Self‐Organizing Maps: Cross‐Activities of Metabotropic Glutamate Receptor Antagonists , 2006, ChemMedChem.
[10] David S. Wishart,et al. Nucleic Acids Research Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs and Metabolites , 2008 .
[11] Sonia Farhana Nimmy,et al. StrucBreak: A Computational Framework for Structural Break Detection in DNA Sequences , 2017, Interdisciplinary Sciences: Computational Life Sciences.
[12] R. Sharan,et al. PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.
[13] Nilanjan Dey,et al. De-Bruijn graph with MapReduce framework towards metagenomic data classification , 2017 .
[14] Gianfranco Balbo,et al. Exploiting flow equivalent server in transient analysis , 2016, Comput. Syst. Sci. Eng..
[15] Nilanjan Dey,et al. Hidden Markov model and Chapman Kolmogrov for protein structures prediction from images , 2017, Comput. Biol. Chem..
[16] Nataša Pržulj,et al. Methods for biological data integration: perspectives and challenges , 2015, Journal of The Royal Society Interface.
[17] Yi Pan,et al. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm , 2016, Bioinform..
[18] Gerd Geisslinger,et al. Drug Repurposing for the Development of Novel Analgesics. , 2016, Trends in pharmacological sciences.
[19] Reda Alhajj,et al. Multi-objective optimization based location and social network aware recommendation , 2014, 10th IEEE International Conference on Collaborative Computing: Networking, Applications and Worksharing.
[20] Di He,et al. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing , 2016, PLoS Comput. Biol..
[21] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[22] Dragomir R. Radev,et al. Identifying gene-disease associations using centrality on a literature mined gene-interaction network , 2008, ISMB.
[23] A. Chiang,et al. Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses , 2009, Clinical pharmacology and therapeutics.
[24] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[25] Mohammed Al-Shalalfa,et al. Prediction of novel drug indications using network driven biological data prioritization and integration , 2014, Journal of Cheminformatics.
[26] Xiaoyan Zhu,et al. Building Disease-Specific Drug-Protein Connectivity Maps from Molecular Interaction Networks and PubMed Abstracts , 2009, PLoS Comput. Biol..
[27] Alexander A. Morgan,et al. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.
[28] Anton Yuryev,et al. Computational Approaches for Drug Repositioning and Combination Therapy Design , 2010, J. Bioinform. Comput. Biol..
[29] Sazia Parvin,et al. Performance evaluation comparison for detecting DNA structural break through big data analysis , 2016, Comput. Syst. Sci. Eng..
[30] Nasser Ghadiri,et al. A review of network‐based approaches to drug repositioning , 2018, Briefings Bioinform..
[31] Zoran Obradovic,et al. Computational Drug Repositioning by Ranking and Integrating Multiple Data Sources , 2013, ECML/PKDD.
[32] Lisa Bastarache,et al. Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics. , 2017, Assay and drug development technologies.
[33] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[34] Joel Dudley,et al. Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..
[35] Nilanjan Dey,et al. Evolutionary framework for coding area selection from cancer data , 2018, Neural Computing and Applications.
[36] Ruth Nussinov,et al. Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.
[37] Luonan Chen,et al. Network-based drug repositioning. , 2013, Molecular bioSystems.
[38] Reda Alhajj,et al. Inference of gene regulatory networks via multiple data sources and a recommendation method , 2015, 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[39] Zhiyong Lu,et al. A new method for computational drug repositioning using drug pairwise similarity , 2012, 2012 IEEE International Conference on Bioinformatics and Biomedicine.